a multicenter phase iii trial comparing irinotecan-gemcitabine (ig) with gemcitabine (g) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreati..
本文档由 gt8s4v 分享于2016-03-07 21:30
a multicenter phase iii trial comparing irinotecan-gemcitabine (ig) with gemcitabine (g) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~